Genotype-Dependent Differences in Sleep, Vigilance, and Response to Stimulants

Author(s): Hans-Peter Landolt.

Journal Name: Current Pharmaceutical Design

Volume 14 , Issue 32 , 2008

Become EABM
Become Reviewer

Abstract:

To better understand the neurobiology of sleep disorders, detailed understanding of circadian and homeostatic sleep-wake regulation in healthy volunteers is mandatory. Sleep physiology and the repercussions of experimentallyinduced sleep deprivation on sleep and waking electroencephalogram (EEG), vigilance and subjective state are highly variable, even in healthy individuals. Accumulating evidence suggests that many aspects of normal sleep-wake regulation are at least in part genetically controlled. Current heritability estimates of sleep phenotypes vary between approximately 20-40 % for habitual sleep duration, to over 90 % for the spectral characteristics of the EEG in nonREM sleep. The molecular mechanisms underlying the trait-like, inter-individual variation are virtually unknown, and the human genetics of normal sleep is only at the beginning of being explored. The first studies identified distinct polymorphisms in genes contributing to the endogenous circadian clock and neurochemical systems previously implicated in sleep-wake regulation, to modulate sleep architecture and sleep EEG, vulnerability to sleep loss, and subjective and objective effects of caffeine on sleep. These insights are reviewed here. They disclose molecular mechanisms contributing to normal sleep-wake regulation in humans, and have potentially important implications for the neurobiology of sleep-wake disorders and their pharmacological treatment.

Keywords: Candidate gene, genome-wide association, pharmacogenetics, PER3, adenosine, serotonin, dopamine, modafinil

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 14
ISSUE: 32
Year: 2008
Page: [3396 - 3407]
Pages: 12
DOI: 10.2174/138161208786549344
Price: $58

Article Metrics

PDF: 9